Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension
暂无分享,去创建一个
Hyun-Young Park | K. Sung | G. Reaven | Hyun-Young Park | Gerald Reaven | Ki-Chul Sung | Min-Ju Kim | Min-Ju Kim
[1] S. Anderson,et al. Usual Blood Pressure and Risk of New-Onset Diabetes , 2015, Journal of the American College of Cardiology.
[2] P. Weidmann,et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. , 1991, The American journal of medicine.
[3] Resistance to insulin-stimulated-glucose uptake in patients with hypertension. , 1987, The Journal of clinical endocrinology and metabolism.
[4] G. Reaven,et al. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high‐density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria , 2013, Journal of internal medicine.
[5] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[6] D. Mozaffarian,et al. Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study. , 2013, American journal of epidemiology.
[7] I. Njølstad,et al. Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of The Tromsø Study , 2010, European Journal of Epidemiology.
[8] Hyun-Young Park,et al. Hypertension is an independent risk factor for type 2 diabetes: the Korean genome and epidemiology study , 2015, Hypertension Research.
[9] S. Kahn,et al. Differential Association Between HDL Subclasses and the Development of Type 2 Diabetes in a Prospective Study of Japanese Americans , 2015, Diabetes Care.
[10] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[11] G. Reaven,et al. Relationship Between the Plasma Insulin Response to Oral Glucose and Insulin-stimulated Glucose Utilization in Normal Subjects , 1984, Diabetes.
[12] G. Reaven,et al. Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations , 1992, Journal of internal medicine.
[13] G. Reaven,et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. , 2012, The American journal of cardiology.
[14] W. Garvey,et al. Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: Stability of metabolic health status in adults , 2016, Obesity.
[15] Y. Ahn,et al. Geographical difference in the prevalence of isolated systolic hypertension in middle-aged men and women in Korea: the Korean Health and Genome Study , 2005, Journal of Human Hypertension.
[16] Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents , 1993, The Lancet.
[17] E. Bonora,et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. , 1989, The New England journal of medicine.
[18] G. Reaven,et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. , 1999, Metabolism: clinical and experimental.
[19] G. Reaven,et al. Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. , 1992, American journal of hypertension.
[20] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[21] E. Ravussin,et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.
[22] G. Reaven,et al. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. , 2000, Diabetes care.
[23] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[24] E. Ferrannini,et al. Insulin resistance in essential hypertension. , 1987, The New England journal of medicine.
[25] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[26] C. Berne,et al. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. , 1990, Metabolism: clinical and experimental.
[27] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, Journal of the American Medical Association (JAMA).
[28] C. Lamendola,et al. Insulin resistance and cardiovascular disease risk factors in subjects with prehypertension , 2011, Diabetes & vascular disease research.
[29] G. Reaven. Relationships Among Insulin Resistance, Type 2 Diabetes, Essential Hypertension, and Cardiovascular Disease: Similarities and Differences , 2011, Journal of clinical hypertension.
[30] R. Krauss,et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? , 2005, The American journal of cardiology.
[31] C. Lamendola,et al. Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. , 2009, American journal of hypertension.
[32] G. Reaven. Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.
[33] P. Zimmet,et al. Diagnosis and classification of diabetes mellitus , 2002 .
[34] J. Viikari,et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents , 1995, Diabetologia.